1-3 of 3
Lubomir Sokol, M.D.
Close
Sort by
Journal Articles

HTLV-1 Epitope (BA21) Reactivity in Rare Bone Marrow Failure Diseases

Susan Bell Nyland, Ph.D., Daniel J. Krissinger, Michael Clemente, M.S., Rosalyn B. Irby, Ph.D., Kendall Thomas Baab, Nancy Ruth Jarbadan, Lubomir Sokol, M.D., Ph.D., Eric Schaefer, M.S., Jason Liao, Ph.D., David Cuthbertson, M.S., P.K. Epling-Burnette, PharmD, PhD, Ronald Paquette, MD, PhD, Jaroslaw P. Maciejewski, MD, PhD, FACP, Thomas P. Loughran, Jr., M.D.
Journal: Blood
Blood (2010) 116 (21): 1724.
https://doi.org/10.1182/blood.V116.21.1724.1724
Published: 2010
Journal Articles

Gene Dosage of the Cell Cycle Regulatory Phosphatases Cdc25C and PP2A Determines Sensitivity to Lenalidomide in del(5q) MDS.

Sheng Wei, MD, Kathy Rocha, BS, Ann Williams, Ph.D., Xianhong Chen, Ph.D, P.K. Burnette, Ph.D., Julie Y. Djeu, Ph.D., Qing Liu, Ph.D., John Byrd, M.D., Lubomir Sokol, M.D., Nick Lawrence, Ph.D., Roberta Pireddu, Ph.D, Gordon Dewald, Ph.D., Jaroslaw Maciejewski, M.D., Alan List, M.D.
Journal: Blood
Blood (2007) 110 (11): 118.
https://doi.org/10.1182/blood.V110.11.118.118
Published: 2007
Journal Articles

Lenalidomide (CC-5013; Revlimid®) Promotes Erythropoiesis in Myelodysplastic Syndromes (MDS) by CD45 Protein Tyrosine Phosphatase (PTP) Inhibition.

Alan F. List, MD, Myka Estes, Ann Williams, Ph.D., Madhavi Sekharam, Ph.D., Ukiyasu Ozawa, Ph.D., Gui Gao, M.D., Ph.D., Jerry Wu, Ph.D., Gui Gao, M.D., Ph.D., Lubomir Sokol, M.D., Ph.D.
Journal: Blood
Blood (2006) 108 (11): 1360.
https://doi.org/10.1182/blood.V108.11.1360.1360
Published: 2006